TIDMGSK

RNS Number : 6628Z

GlaxoSmithKline PLC

13 January 2020

GlaxoSmithKline plc (the 'Company')

Transaction notification

 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
===  ================================================================================ 
 a)   Name                          Ms E Walmsley 
===  =============================  ================================================= 
 b)   Position/status               Chief Executive Officer 
===  =============================  ================================================= 
 c)   Initial notification/         Initial notification 
       amendment 
===  =============================  ================================================= 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ================================================================================ 
 a)   Name                          GlaxoSmithKline plc 
===  =============================  ================================================= 
 b)   LEI                           5493000HZTVUYLO1D793 
===  =============================  ================================================= 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ================================================================================ 
 a)   Description of                Ordinary shares of 25 pence each ('Ordinary 
       the financial                 Shares') 
       instrument                    ISIN: GB0009252882 
===  =============================  ================================================= 
 b)   Nature of the                 Acquisition of Ordinary Shares under the 
       transaction                   Company's Share Reward Plan. 
===  =============================  ================================================= 
 c)   Price(s) and                    Price(s)      Volume(s) 
       volume(s) 
===  =============================    ============  =============================== 
                                      GBP18.00      7 (partnership shares) 
===  =============================    ============  =============================== 
                                      GBP18.00      7 (matching shares) 
                                      ============  =============================== 
 
 d)   Aggregated information 
=== 
      Aggregated volume             14 Ordinary Shares 
       Price                         GBP18.00 
===  =============================  ================================================= 
 e)   Date of the transaction       2020-01-10 
===  =============================  ================================================= 
 f)   Place of the                  London Stock Exchange (XLON) 
       transaction 
===  =============================  ================================================= 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
===  ================================================================================ 
 a)   Name                          Mr R Connor 
===  =============================  ================================================= 
 b)   Position/status               President, Global Vaccines 
===  =============================  ================================================= 
 c)   Initial notification/         Initial notification 
       amendment 
===  =============================  ================================================= 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ================================================================================ 
 a)   Name                          GlaxoSmithKline plc 
===  =============================  ================================================= 
 b)   LEI                           5493000HZTVUYLO1D793 
===  =============================  ================================================= 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ================================================================================ 
 a)   Description of                Ordinary shares of 25 pence each ('Ordinary 
       the financial                 Shares') 
       instrument                    ISIN: GB0009252882 
===  =============================  ================================================= 
 b)   Nature of the                 Acquisition of Ordinary Shares under the 
       transaction                   Company's Share Reward Plan. 
===  =============================  ================================================= 
 c)   Price(s) and                    Price(s)      Volume(s) 
       volume(s) 
===  =============================    ============  =============================== 
                                      GBP18.00      7 (partnership shares) 
===  =============================    ============  =============================== 
                                      GBP18.00      7 (matching shares) 
                                      ============  =============================== 
 
 d)   Aggregated information 
=== 
      Aggregated volume             14 Ordinary Shares 
       Price                         GBP18.00 
===  =============================  ================================================= 
 e)   Date of the transaction       2020-01-10 
===  =============================  ================================================= 
 f)   Place of the                  London Stock Exchange (XLON) 
       transaction 
===  =============================  ================================================= 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
===  ================================================================================ 
 a)   Name                          Ms D Conrad 
===  =============================  ================================================= 
 b)   Position/status               SVP, Human Resources 
===  =============================  ================================================= 
 c)   Initial notification/         Initial notification 
       amendment 
===  =============================  ================================================= 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ================================================================================ 
 a)   Name                          GlaxoSmithKline plc 
===  =============================  ================================================= 
 b)   LEI                           5493000HZTVUYLO1D793 
===  =============================  ================================================= 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ================================================================================ 
 a)   Description of                Ordinary shares of 25 pence each ('Ordinary 
       the financial                 Shares') 
       instrument                    ISIN: GB0009252882 
===  =============================  ================================================= 
 b)   Nature of the                 Acquisition of Ordinary Shares under the 
       transaction                   Company's Share Reward Plan. 
===  =============================  ================================================= 
 c)   Price(s) and                    Price(s)      Volume(s) 
       volume(s) 
===  =============================    ============  =============================== 
                                      GBP18.00      7 (partnership shares) 
===  =============================    ============  =============================== 
                                      GBP18.00      7 (matching shares) 
                                      ============  =============================== 
 
 d)   Aggregated information 
=== 
      Aggregated volume             14 Ordinary Shares 
       Price                         GBP18.00 
===  =============================  ================================================= 
 e)   Date of the transaction       2020-01-10 
===  =============================  ================================================= 
 f)   Place of the                  London Stock Exchange (XLON) 
       transaction 
===  =============================  ================================================= 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
===  ================================================================================ 
 a)   Name                          Mr N Hirons 
===  =============================  ================================================= 
 b)   Position/status               SVP, Global Ethics and Compliance 
===  =============================  ================================================= 
 c)   Initial notification/         Initial notification 
       amendment 
===  =============================  ================================================= 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ================================================================================ 
 a)   Name                          GlaxoSmithKline plc 
===  =============================  ================================================= 
 b)   LEI                           5493000HZTVUYLO1D793 
===  =============================  ================================================= 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ================================================================================ 
 a)   Description of                Ordinary shares of 25 pence each ('Ordinary 
       the financial                 Shares') 
       instrument                    ISIN: GB0009252882 
===  =============================  ================================================= 
 b)   Nature of the                 Acquisition of Ordinary Shares under the 
       transaction                   Company's Share Reward Plan. 
===  =============================  ================================================= 
 c)   Price(s) and                    Price(s)      Volume(s) 
       volume(s) 
===  =============================    ============  =============================== 
                                      GBP18.00      7 (partnership shares) 
===  =============================    ============  =============================== 
                                      GBP18.00      7 (matching shares) 
                                      ============  =============================== 
 
 d)   Aggregated information 
=== 
      Aggregated volume             14 Ordinary Shares 
       Price                         GBP18.00 
===  =============================  ================================================= 
 e)   Date of the transaction       2020-01-10 
===  =============================  ================================================= 
 f)   Place of the                  London Stock Exchange (XLON) 
       transaction 
===  =============================  ================================================= 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
===  ================================================================================ 
 a)   Name                          Ms S Jackson 
===  =============================  ================================================= 
 b)   Position/status               SVP, Global Communications and CEO Office 
===  =============================  ================================================= 
 c)   Initial notification/         Initial notification 
       amendment 
===  =============================  ================================================= 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ================================================================================ 
 a)   Name                          GlaxoSmithKline plc 
===  =============================  ================================================= 
 b)   LEI                           5493000HZTVUYLO1D793 
===  =============================  ================================================= 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ================================================================================ 
 a)   Description of                Ordinary shares of 25 pence each ('Ordinary 
       the financial                 Shares') 
       instrument                    ISIN: GB0009252882 
===  =============================  ================================================= 
 b)   Nature of the                 Acquisition of Ordinary Shares under the 
       transaction                   Company's Share Reward Plan. 
===  =============================  ================================================= 
 c)   Price(s) and                    Price(s)      Volume(s) 
       volume(s) 
===  =============================    ============  =============================== 
                                      GBP18.00      7 (partnership shares) 
===  =============================    ============  =============================== 
                                      GBP18.00      7 (matching shares) 
                                      ============  =============================== 
 
 d)   Aggregated information 
=== 
      Aggregated volume             14 Ordinary Shares 
       Price                         GBP18.00 
===  =============================  ================================================= 
 e)   Date of the transaction       2020-01-10 
===  =============================  ================================================= 
 f)   Place of the                  London Stock Exchange (XLON) 
       transaction 
===  =============================  ================================================= 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
===  ==================================================================================== 
 a)   Name                          Mr D Jackson 
===  =============================  ===================================================== 
 b)   Position/status               PCA of Ms S Jackson (SVP, Global Communications 
                                     and CEO Office) 
===  =============================  ===================================================== 
 c)   Initial notification/         Initial notification 
       amendment 
===  =============================  ===================================================== 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ==================================================================================== 
 a)   Name                          GlaxoSmithKline plc 
===  =============================  ===================================================== 
 b)   LEI                           5493000HZTVUYLO1D793 
===  =============================  ===================================================== 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ==================================================================================== 
 a)   Description of                Ordinary shares of 25 pence each ('Ordinary 
       the financial                 Shares') 
       instrument                    ISIN: GB0009252882 
===  =============================  ===================================================== 
 b)   Nature of the                 Acquisition of Ordinary Shares under the 
       transaction                   Company's Share Reward Plan. 
===  =============================  ===================================================== 
 c)   Price(s) and                    Price(s)        Volume(s) 
       volume(s) 
===  =============================    ==============  ================================= 
                                      GBP18.00        7 (partnership shares) 
===  =============================    ==============  ================================= 
                                      GBP18.00        7 (matching shares) 
                                      ==============  ================================= 
 
 d)   Aggregated information 
=== 
      Aggregated volume             14 Ordinary Shares 
       Price                         GBP18.00 
===  =============================  ===================================================== 
 e)   Date of the transaction       2020-01-10 
===  =============================  ===================================================== 
 f)   Place of the                  London Stock Exchange (XLON) 
       transaction 
===  =============================  ===================================================== 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
===  ================================================================================ 
 a)   Name                          Mr D Redfern 
===  =============================  ================================================= 
 b)   Position/status               Chief Strategy Officer 
===  =============================  ================================================= 
 c)   Initial notification/         Initial notification 
       amendment 
===  =============================  ================================================= 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ================================================================================ 
 a)   Name                          GlaxoSmithKline plc 
===  =============================  ================================================= 
 b)   LEI                           5493000HZTVUYLO1D793 
===  =============================  ================================================= 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ================================================================================ 
 a)   Description of                Ordinary shares of 25 pence each ('Ordinary 
       the financial                 Shares') 
       instrument                    ISIN: GB0009252882 
===  =============================  ================================================= 
 b)   Nature of the                 Acquisition of Ordinary Shares under the 
       transaction                   Company's Share Reward Plan. 
===  =============================  ================================================= 
 c)   Price(s) and                    Price(s)      Volume(s) 
       volume(s) 
===  =============================    ============  =============================== 
                                      GBP18.00      7 (partnership shares) 
===  =============================    ============  =============================== 
                                      GBP18.00      7 (matching shares) 
                                      ============  =============================== 
 
 d)   Aggregated information 
=== 
      Aggregated volume             14 Ordinary Shares 
       Price                         GBP18.00 
===  =============================  ================================================= 
 e)   Date of the transaction       2020-01-10 
===  =============================  ================================================= 
 f)   Place of the                  London Stock Exchange (XLON) 
       transaction 
===  =============================  ================================================= 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
===  ================================================================================ 
 a)   Name                          Mr R Simard 
===  =============================  ================================================= 
 b)   Position/status               President, Pharmaceuticals Supply Chain 
===  =============================  ================================================= 
 c)   Initial notification/         Initial notification 
       amendment 
===  =============================  ================================================= 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ================================================================================ 
 a)   Name                          GlaxoSmithKline plc 
===  =============================  ================================================= 
 b)   LEI                           5493000HZTVUYLO1D793 
===  =============================  ================================================= 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ================================================================================ 
 a)   Description of                Ordinary shares of 25 pence each ('Ordinary 
       the financial                 Shares') 
       instrument                    ISIN: GB0009252882 
===  =============================  ================================================= 
 b)   Nature of the                 Acquisition of Ordinary Shares under the 
       transaction                   Company's Share Reward Plan. 
===  =============================  ================================================= 
 c)   Price(s) and                    Price(s)      Volume(s) 
       volume(s) 
===  =============================    ============  =============================== 
                                      GBP18.00      7 (partnership shares) 
===  =============================    ============  =============================== 
                                      GBP18.00      7 (matching shares) 
                                      ============  =============================== 
 
 d)   Aggregated information 
=== 
      Aggregated volume             14 Ordinary Shares 
       Price                         GBP18.00 
===  =============================  ================================================= 
 e)   Date of the transaction       2020-01-10 
===  =============================  ================================================= 
 f)   Place of the                  London Stock Exchange (XLON) 
       transaction 
===  =============================  ================================================= 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
===  ================================================================================ 
 a)   Name                          Mr P Thomson 
===  =============================  ================================================= 
 b)   Position/status               President, Global Affairs 
===  =============================  ================================================= 
 c)   Initial notification/         Initial notification 
       amendment 
===  =============================  ================================================= 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ================================================================================ 
 a)   Name                          GlaxoSmithKline plc 
===  =============================  ================================================= 
 b)   LEI                           5493000HZTVUYLO1D793 
===  =============================  ================================================= 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ================================================================================ 
 a)   Description of                Ordinary shares of 25 pence each ('Ordinary 
       the financial                 Shares') 
       instrument                    ISIN: GB0009252882 
===  =============================  ================================================= 
 b)   Nature of the                 Acquisition of Ordinary Shares under the 
       transaction                   Company's Share Reward Plan. 
===  =============================  ================================================= 
 c)   Price(s) and                    Price(s)      Volume(s) 
       volume(s) 
===  =============================    ============  =============================== 
                                      GBP18.00      7 (partnership shares) 
===  =============================    ============  =============================== 
                                      GBP18.00      7 (matching shares) 
                                      ============  =============================== 
 
 d)   Aggregated information 
=== 
      Aggregated volume             14 Ordinary Shares 
       Price                         GBP18.00 
===  =============================  ================================================= 
 e)   Date of the transaction       2020-01-10 
===  =============================  ================================================= 
 f)   Place of the                  London Stock Exchange (XLON) 
       transaction 
===  =============================  ================================================= 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
===  ================================================================================ 
 a)   Name                          Ms D Waterhouse 
===  =============================  ================================================= 
 b)   Position/status               Chief Executive Officer of ViiV Healthcare 
===  =============================  ================================================= 
 c)   Initial notification/         Initial notification 
       amendment 
===  =============================  ================================================= 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ================================================================================ 
 a)   Name                          GlaxoSmithKline plc 
===  =============================  ================================================= 
 b)   LEI                           5493000HZTVUYLO1D793 
===  =============================  ================================================= 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ================================================================================ 
 a)   Description of                Ordinary shares of 25 pence each ('Ordinary 
       the financial                 Shares') 
       instrument                    ISIN: GB0009252882 
===  =============================  ================================================= 
 b)   Nature of the                 Acquisition of Ordinary Shares under the 
       transaction                   Company's Share Reward Plan. 
===  =============================  ================================================= 
 c)   Price(s) and                    Price(s)      Volume(s) 
       volume(s) 
===  =============================    ============  =============================== 
                                      GBP18.00      7 (partnership shares) 
===  =============================    ============  =============================== 
                                      GBP18.00      7 (matching shares) 
                                      ============  =============================== 
 
 d)   Aggregated information 
=== 
      Aggregated volume             14 Ordinary Shares 
       Price                         GBP18.00 
===  =============================  ================================================= 
 e)   Date of the transaction       2020-01-10 
===  =============================  ================================================= 
 f)   Place of the                  London Stock Exchange (XLON) 
       transaction 
===  =============================  ================================================= 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
===  ================================================================================ 
 a)   Name                          Ms V Whyte 
===  =============================  ================================================= 
 b)   Position/status               Company Secretary 
===  =============================  ================================================= 
 c)   Initial notification/         Initial notification 
       amendment 
===  =============================  ================================================= 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ================================================================================ 
 a)   Name                          GlaxoSmithKline plc 
===  =============================  ================================================= 
 b)   LEI                           5493000HZTVUYLO1D793 
===  =============================  ================================================= 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ================================================================================ 
 a)   Description of                Ordinary shares of 25 pence each ('Ordinary 
       the financial                 Shares') 
       instrument                    ISIN: GB0009252882 
===  =============================  ================================================= 
 b)   Nature of the                 Acquisition of Ordinary Shares under the 
       transaction                   Company's Share Reward Plan. 
===  =============================  ================================================= 
 c)   Price(s) and                    Price(s)      Volume(s) 
       volume(s) 
===  =============================    ============  =============================== 
                                      GBP18.00      7 (partnership shares) 
===  =============================    ============  =============================== 
                                      GBP18.00      7 (matching shares) 
                                      ============  =============================== 
 
 d)   Aggregated information 
=== 
      Aggregated volume             14 Ordinary Shares 
       Price                         GBP18.00 
===  =============================  ================================================= 
 e)   Date of the transaction       2020-01-10 
===  =============================  ================================================= 
 f)   Place of the                  London Stock Exchange (XLON) 
       transaction 
===  =============================  ================================================= 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHDXLFFBFLEBBQ

(END) Dow Jones Newswires

January 13, 2020 13:00 ET (18:00 GMT)

Grafico Azioni Gsk (LSE:GSK)
Storico
Da Feb 2024 a Mar 2024 Clicca qui per i Grafici di Gsk
Grafico Azioni Gsk (LSE:GSK)
Storico
Da Mar 2023 a Mar 2024 Clicca qui per i Grafici di Gsk